Abstract:Background Accelerometers and patient-reported outcomes (PRO) are used to assess physical activity (PA) in people with multiple sclerosis (pwMS). So far it is unknown, however, whether these assessments represent mobility limitations in pwMS with mild and moderate to severe disability alike. The primary aim of the study was to assess the correlation between accelerometry and International Physical Activity Questionnaire (IPAQ) scores in pwMS with different degrees of ambulatory impairment. Taken its frequent use into account, the Godin Leisure Time Exercise Questionnaire (GLTEQ) was investigated as additional PRO. Methods In a prospective cohort of pwMS, correlational analyses were performed between the number of daily steps, time spent in light, moderate to vigorous PA (MVPA) and time spent sitting as assessed using accelerometry (ActiGraph®-GT3X), and the respective IPAQ and GLTEQ scores. Additionally, associations of PA with disease-specific characteristics, aerobic capacity (VO2 peak ), walking assessments (Timed 25-Foot Walk, T25FW; 2-Minute Walk Test, 2MWT) and walking perception (Multiple Sclerosis Walking Scale-12; MSWS-12) were explored. Patient subgroups with mild (Expanded Disability Status Scale; EDSS score <4.0) and moderate to severe disability (EDSS ≥4.0) were analysed for the impact of ambulatory impairment on PA. Multiple linear regression was used to determine predictors of PA. Results A total of 56 pwMS completed the study, with a mean (standard deviation, SD) age of 48.4 (10.3) years, disease duration of 14.8 (9.6) years and median (interquartile range) EDSS score of 3.5 (2.0 – 4.4). Moderate to weak correlations were found between daily step count and IPAQ total metabolic equivalent (MET) minutes/week (p<0.001; r=0.506), MVPA MET-minutes/week (p<0.01; r=0.479) and walking MET-minutes/week (p<0.05; r=0.372) in the total cohort. Time spent sitting was inversely correlated with total MET-minutes/week and MVPA MET-minutes/week (p<0.05; r= -0.358 and r= -0.365). Subgroup analysis revealed, that daily step count was significantly correlated with total MET-minutes/week, MVPA MET-minutes/week and walking MET-minutes/week (p<0.01, r=0.569; p<0.01, r=0.531 and p<0.05, r=0.480 respectively) in the "mild disability" subgroup only, whereas time spent sitting was inversely correlated with total MET-minutes/week (p<0.05; r= -0.582) in the "moderate to severe disability" subgroup. There was no association between objectively assessed PA and GLTEQ scores in any group. In the total cohort, moderate to weak correlations were found between daily step count and walking assessments (T25FW: p<0.01, ρ= -0.508; 2MWT: p<0.01, ρ=0.463) and MSWS-12 (p<0.001; ρ= -0.609). Moderate to weak correlations were also observed between VO2 peak and walking assessments (T25FW: p<0.01; ρ= -0.516; 2MWT: p<0.01, ρ=0.480). Multiple linear regression analysis identified disability and VO2 peak as predictors of PA (p=0.045; β=0.25 and p<0.001; β=0.49). Conclusion Significant associations of objective PA measurements using accelerometry with IPAQ were found only in pwMS with "mild disability". In pwMS with "moderate to severe disability", IPAQ did not reflect the objectively assessed amount of PA. In our cohort, GLTEQ showed no association with objectively assessed PA. Thus, an MS-specific self-reported questionnaire for assessing PA is warranted.

Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes

A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease

Psychometric Properties of Patient-Reported Outcome Measures, measuring Fatigue in patients with Multiple Sclerosis, a Systematic Review

Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis

339P Exploring the content validity of Patient-Reported Outcome (PRO) measures to capture the patient experience of Becker muscular dystrophy (BMD)

Abstract TP97: Feasibility and Reliability of Patient-Reported Scores to Assess Long-Term Functional Outcomes in Stroke: A Sub-Group Analysis of the MaRISS Trial

Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: a cross-sectional study

Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study

Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis

MyMS: An Interface for Patient-Reported Outcomes for Finnish Individuals With Multiple Sclerosis

Prospective Memory Complaints are Related to Objective Performance in People with Multiple Sclerosis

Patient-reported outcomes and quality of life in PMM2-CDG

A systematic literature review of the measurement of patient-reported fatigue in studies of disease modifying therapies for multiple sclerosis

Predictors of six-month change in health-related quality of life in people with multiple sclerosis: A secondary data analysis of a randomized controlled trial

Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sample

The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics

Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes

Mobility trajectories in multiple sclerosis: A comparative study of timed 25-foot walk and a patient-reported outcome measure

Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions.

Using a Patient-Reported Outcome Measure to Assess Physical, Psychosocial, and Existential Issues in COPD

Patient-Reported Physical Function Measures in Cancer Clinical Trials.